Gene therapy randomised clinical trials in Europe – a review paper of methodology and design by Krassimira Ilieva, Borislav Borissov, Mondher Toumi

Get full text

Patient-reported outcome claims in European and United States orphan drug approvals by Szymon Jarosławski, Pascal Auquier, Borislav Borissov, Claude Dussart, Mondher Toumi

Get full text

Cost-effectiveness of evolocumab in treatment of heterozygous familial hypercholesterolaemia in Bulgaria: measuring health benefit by effectively treated patient-years* by Borislav Borissov, Michael Urbich, Boryana Georgieva, Svetoslav Tsenov, Guillermo Villa

Get full text

Low rates of patient-reported outcome claims for orphan drugs approved by the us food and drug administration by Szymon Jarosławski, Pascal Auquier, Borislav Borissov, Claude Dussart, Mondher Toumi

Get full text

Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease by Michal Pochopien, Jakub Wladyslaw Dziedzic, Samuel Aballea, Emilie Clay, Iwona Zerda, Mondher Toumi, Borislav Borissov

Get full text

Why “American Patients First” is likely to raise drug prices outside of the United States by Monique Dabbous, Cyprien Milea, Steven Simoens, Clement François, Claude Dussart, Lylia Chachoua, Borislav Borissov, Mondher Toumi

Get full text